You are here: Home :: Area NEM :: Medical science :: Human medicine

Sam Schulman, Mats gren

New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism

Keywords: Venous thromboembolism, risk factors, recurrence, bleeding

Recent trials on secondary prophylaxis after venous thromboembolism (VTE) have provided a wealth of data on the risk factors for recurrence and, to some extent, also for bleeding. Some of the results are consistent across the studies, but there are also conflicting data. Certain risk factors, such as pulmonary embolism versus deep vein thrombosis or presence of cardiolipin antibodies, have a more pronounced influence on the risk early in the course of disease. Others, such as hereditary thrombophilic defects, seem to gain importance over many years of follow-up. Therefore, it can be difficult to make decisions on an individual patient basis. In this article, data from important and illustrative trials have been extracted and compared and controversies highlighted. The conclusions drawn should help clinicians make balanced decisions on the optimal duration of anticoagulation after an episode of VTE.

Thrombosis and Haemostasis, Schattauer

Print ISSN: 0340-6245
Volume: 96, 09/2006
Pages: 258 - 266

Show full article (external site)

Show all available items of this journal

 

Area NEM